Catamaran Achieves Five-Star Medication Safety Ratings, Drives Improved
LISLE, IL, May 30, 2013 /CNW/ - Catamaran Corp. (NASDAQ: CTRX, TSX:
CCT), a leading provider of pharmacy benefit management (PBM) services
and technology, today announced it has received a 2013 PQA Quality
Award recognizing its five-star rating on all PQA measures in the Part
D Star Ratings program.
The award is administered by Pharmacy Quality Alliance (PQA), an
organization dedicated to improving patient health by championing clear
performance measures for medication management, and recognizes those
organizations that foster exceptional pharmacy quality.
"We are honored to be recognized by PQA for our commitment to
continuously enhancing the quality of care in the Medicare arena," said
Mark Thierer, Chairman and Chief Executive Officer of Catamaran. "By
leveraging our resources, skill, and scale, Catamaran has achieved
powerful results in improving health outcomes and reducing costs, all
with a laser-sharp focus on patient safety."
PQA's recognition program for prescription drug plans recognizes
Medicare prescription drug plans (both MA-PD and PDP) that have
demonstrated outstanding performance in medication-related quality as
determined through the use of publicly-available performance data for
Medicare Part D.
"Catamaran Corporation has achieved industry-leading safety scores in
the care of its Medicare members, meeting PQA's standards of excellence
for this year's Quality Recognition Award," said Laura Cranston, PQA's
Executive Director. "Catamaran serves as a model for the high outcomes
that are possible when innovation and commitment come together across
The award was formally presented at PQA's annual meeting and luncheon on
May 29, 2013. This is the third year the consensus-based,
multi-stakeholder organization provided this unique recognition to top
healthcare providers administrating Medicare prescription services
across the nation.
There are five PQA-endorsed quality measures that are used within the
CMS' Medicare Star Ratings program. Details on these measures are
available at the PQA website: www.PQAalliance.org
Catamaran, the industry's fastest-growing pharmacy benefits manager,
helps organizations and the communities they serve take control of
prescription drug costs. Managing more than 250 million prescriptions
each year on behalf of 25 million members, our flexible, holistic
solutions improve patient care and empower individuals to take charge
of their health. Processing one in every five prescription claims in
the U.S., Catamaran's skill and scale deliver compelling financial
results and sustainable improvement in the overall health of members.
Catamaran is headquartered in Lisle, Ill. with multiple locations in
the U.S. and Canada. For more information, please visit www.catamaranRx.com.
Established in 2006, PQA represents pharmacy providers, pharmacy benefit
managers, health plans, academicians, consumer advocates, employers,
pharmaceutical research and manufacturing companies, and other
stakeholders interested in improving the quality of the medication-use
system. PQA's mission is to: Improve the quality of medication management and use across health care
settings with the goal of improving patients' health through a
collaborative process to develop and implement performance measures and
recognize examples of exceptional pharmacy quality.
PQA provides a leadership role in identification and selection of
metrics for evaluation of the quality of the medication-use system,
provides education on quality improvement, and connects pharmacists to
healthcare improvement initiatives.
For further information:
Tel: (312) 261-7805